IMIDomics, Inc. is a biotechnology company focused on the discovery and development of new medicines for the treatment of immune-mediated inflammatory diseases (IMIDs).
Location: Spain, Catalonia, Barcelona
Employees: 11-50
Total raised: $16.5M
Investors 1
| Date | Name | Website |
| - | DNS Capita... | dnscap.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.07.2021 | Series A | $16.5M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 28.07.2021 | IMIDomics cierra una ronda de $16,5M a la que acuden DNS Cap... | 28/07/2021 Nota de prensa IMIDOMICS, UN SPIN-OFF DEL VALL D’HEBRON, CONSIGUE $16,5M PARA DESARROLL... | webcapital... |
| 28.07.2021 | TPG and Brookfield add billions to the climate-tech coffers | As interest in climate-tech grows, so are the mega war chests. Paid Content Building a world econom... | fortune.co... |
| 28.07.2021 | TPG and Brookfield add billions to the climate-tech coffers | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 27.07.2021 | IMIDomics emerges with $16.5M, former Takeda exec at the hel... | After 15 years of laying the groundwork, IMIDomics is coming out of the shadows with $16.5 million a... | fiercebiot... |
| 27.07.2021 | IMIDomics Completes $16.5M Series A Financing | IMIDomics Inc., a San Francisco, CA-based drug discovery company focused on patients with immune-med... | finsmes.co... |
| 27.07.2021 | IMIDomics emerges with $16.5M, former Takeda exec at the hel... | After 15 years of laying the groundwork, IMIDomics is coming out of the shadows with $16.5 million a... | fiercebiot... |
| 27.07.2021 | IMIDomics :TM Closes $16.5 Million Series A Financing to Adv... | IMIDomics Inc., a drug discovery company focused on patients with immune-mediated inflammatory disea... | marketscre... |